Archer Investment Corp acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,578 shares of the biopharmaceutical company’s stock, valued at approximately $957,000. A number of other hedge funds [...]
Archer Investment Corp Takes Position in Gilead Sciences, Inc. $GILD
